cas 1006381-03-8|| where to buy (R)-4-methyl-1,3,2-dioxathiolane 2,2-dioxide

Nombre del producto:(R)-4-methyl-1,3,2-dioxathiolane 2,2-dioxide

IUPAC Name:(4R)-4-methyl-1,3,2λ⁶-dioxathiolane-2,2-dione

Unidad de embalaje	Stock disponible	Precio($)
CM199586-1g	in stock	Ȑƿ
CM199586-5g	in stock	ƃŵǑ
CM199586-25g	in stock	Ȑũȡ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1006381-03-8 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :1006381-03-8; Fórmula molecular:C3H6O4S; Punto de fusión:-; Código de sonrisas:C[C@H]1OS(OC1)(=O)=O; Densidad:

: Número de catálogo:CM199586; Peso molecular:138.14; Punto de ebullición:; Nº Mdl:; Almacenamiento:

: Orforglipron; Obesity is becoming an increasingly serious public health problem globally, plaguing millions of people and significantly increasing their risk of chronic diseases such as diabetes and heart disease. In recent years, with the approval of new weight loss drugs such as Wegovy (Semaglutide) and Mounjaro (Tirzepatide), people's attention to this field has once again heated up, spawning an upsurge in the research and development of new treatments. There are currently nearly 70 obesity treatments in the research and development stage. Eli Lilly's Orforglipron is the world's first oral small molecule GLP-1RA to start Phase III clinical trials.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.